Navigation Links
EMBASE Classic Makes Inroads into Pharmaceutical Industry

AMSTERDAM, November 6 /PRNewswire/ --

- Elsevier Signs Agreement With Bayer HealthCare AG

Elsevier announced today that major global healthcare company, Bayer HealthCare AG, headquartered in Leverkusen, Germany, has signed an agreement to purchase EMBASE Classic. Available in electronic format for the first time, EMBASE Classic is a fully digitized bibliographic database drawn from 43 Excerpta Medica Abstract Journals published between 1947 and 1973. Covering approximately 3,400 international journals, EMBASE Classic indexes more than 1.8 million records from the biomedical and pharmacological literature.

For Bayer HealthCare and other healthcare and biopharmaceutical companies already licensing EMBASE (covering the literature published from 1974-present) or accessing the file via one of the online vendors, EMBASE Classic allows effective and efficient searching of a single file, from 1947 until today. An important benefit of the addition of EMBASE Classic to EMBASE is the documentation of toxicities and adverse effects that have been published about drugs or endogenous compounds at the time. These drugs may be revisited today or serve as controls because of their known adverse effects or specific effects in animals. In addition results of clinical trials published prior to 1974 can now be more easily factored into evidence-based medical assessments.

Edith Bomers, Project Manager, EMBASE Classic, commented that, "We are extremely pleased that the value of EMBASE Classic has already been recognized by Bayer HealthCare AG, one of the world's leading healthcare companies. EMBASE Classic makes critical biomedical research from the 1950s and 1960s searchable and easily accessible, facilitating much more effective literature searches. In essence it allows revisiting the past to explore the future."

EMBASE Classic contains historic index terms and has been enhanced with additional indexing controlled by the current version of EMTREE to allow for precision retrieval. EMTREE has furthermore been enhanced with historic index terms. For example, the pre-penicillin era drugs oxophenarsine (tradename mapharsen) to treat syphilis and thiazosulfone (tradename promizole) to treat leprosy and tuberculosis have become EMTREE terms.

EMBASE Classic may be acquired directly from Elsevier or from vendors Ovid, Dialog or DataStar. To celebrate the release of EMBASE Classic, an introductory sales offer is currently available.

Contact Magdaleine Margaritis at for additional information and visit to obtain the complete list of Excerpta Medica Abstract Journal titles/years covered.

About EMBASE (

EMBASE is a biomedical and pharmacological database that provides access to the most up-to-date information about medical and drug-related subjects. Updated weekly, it contains over 11 million records from 1974 to present, with 600,000+ citations and abstracts added annually. Each record contains the full bibliographic citation, indexing terms and codes; 70% of all citations in EMBASE include author-written abstracts. The EMBASE journal collection is international with over 5,000 biomedical journals from 70 countries. EMBASE features comprehensive coverage of Drug Research, Pharmacology, Pharmacy, Pharmacoeconomics, Pharmaceutics and Toxicology; Human Medicine (Clinical and Experimental); Basic Biological Research; Health Policy and Management; Public, Occupational and Environmental Health; Substance Dependence and Abuse; Psychiatry; Forensic Science; and Biomedical Engineering and Instrumentation.

About Elsevier (

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (, MD Consult (, Scopus (, bibliographic databases, and online reference works.

Elsevier ( is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (, a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Magdaleine Margaritis


SOURCE Elsevier B V
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. A classic method for modeling skin cancer is featured in Cold Spring Harbor Protocols
2. New Smart Technology Makes Patient Data Collection Easier, More Efficient
3. WeissComm Partners Makes 10 New Hires as It Wins New Accounts and Grows Existing Business
4. Independence Blue Cross Makes Music for Members Ears
5. A Place for Mom COO Makes Seattles 40 Under 40 List
6. Sesame Street Exhibition Makes Texas Premier at The Health Museum
7. Study makes progress in zoning in on biomarkers for better colon cancer treatment
8. New Online Tool Makes Enrollment in Blue Cross of California Easier
9. 1-800-PACK-RAT Makes a Splash During Annual Walk for Hope
10. Eye on Safety Makes Halloween Less Scary
11. An Industry First: New Cooper Health Company Makes Group Employee Benefits Consulting and Wellness Program Design a Package Deal
Post Your Comments:
(Date:11/24/2015)... MI (PRWEB) , ... November 24, 2015 , ... Serenity ... released a series of recent video interviews with some of the staff members at ... at the residential treatment facility, as well as some of the things that make ...
(Date:11/24/2015)... ... November 24, 2015 , ... Aided by seed funding from the Ron Foley ... to yield insights into how to detect and treat pancreatic cancer (PC). , ... small, non-coding RNA molecules (ncRNA), genetic material that is present in the blood of ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... been designated an Aetna Institute of Quality® Bariatric Surgery Facility for treating individuals ... and cost of health care services available to its members to help them ...
(Date:11/24/2015)... Peoria, IL (PRWEB) , ... November 24, 2015 , ... Dr. Rodney E. Willey ... His new venture, Koala Center for Sleep Disorders, provides treatment for snoring and ... dentists who have opened a Koala Center for Sleep Disorders in the US, one of ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... Healthy Aging Program have announced their endorsement of the Medical Fitness Network ... Fitness is proud to have the MFN as one of our endorsed organizations,” ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... , Nov. 24, 2015   HeartWare International, ... of less-invasive, miniaturized circulatory support technologies that are revolutionizing ... President and Chief Executive Officer Doug Godshall ... th Annual Healthcare Conference on December 1, 2015 ... December 1-2 in New York . ...
(Date:11/24/2015)... 24, 2015 F1000Workspace - a ... since it was launched just six months ago. --> ... authoring platform for scientists - since it was launched just ... been loaded on to F1000Workspace - a research ... it was launched just six months ago. ...
(Date:11/24/2015)... Nov. 24, 2015 iRhythm Technologies, Inc. , a ... today announced that it will participate in the 27th Annual Piper ... New York, NY . Kevin King , ... December 1, 2015 at 8:50am ET. --> ... . --> . --> iRhythm ...
Breaking Medicine Technology: